| 发明名称 | Phosphate-binding magnesium salts and uses thereof | ||
| 摘要 | The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts. | ||
| 申请公布号 | US9339481(B2) | 申请公布日期 | 2016.05.17 |
| 申请号 | US201313856084 | 申请日期 | 2013.04.03 |
| 申请人 | Cypress Pharmaceuticals, Inc. | 发明人 | Lewis Robert L.;Day Charles E. |
| 分类号 | A61K33/06;A61K31/19;A61K31/715;A61K33/08;A61K33/10;A61K31/197;A61K9/28;A61K9/48 | 主分类号 | A61K33/06 |
| 代理机构 | Servilla Whitney LLC | 代理人 | Servilla Whitney LLC |
| 主权项 | 1. A composition suitable for treating hyperphosphatemia comprising a therapeutically effective dose of at least one calcium salt and at least one phosphate-binding magnesium salt, wherein the at least one phosphate-binding magnesium salt comprises magnesium glycinate, and wherein the composition is formulated for oral administration and the composition comprises an enteric coating. | ||
| 地址 | Morristown NJ US | ||